Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
Recruiting · NCT07012759 · Observational (researchers observe without assigning treatment) · Lead sponsor: Fu Jen Catholic University
View the official record on ClinicalTrials.gov →Interventions studied
biomarkers
What this trial is about
This project aims to assess the expression levels of novel molecular markers identified through screening in clinical samples of malignant pleural effusion, to evaluate the feasibility and clinical utility of these markers as potential diagnostic genes for lung adenocarcinoma.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients requiring thoracentesis for pleural effusion drainage as determined by a physician based on clinical need.
- Signed informed consent.
Exclusion criteria
- Patients under the age of 18.
- Patients with malignancies other than lung adenocarcinoma.
Where it is running
1 location listed.
- Fu Jen Catholic University Hospital, Fu Jen Catholic University - New Taipei City, Taiwan